Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42,282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Huo Xiang Zheng Qi Oral Liquid Combined with 5-HT3 Receptor Antagonists and Dexamethasone Can Prevent Chemotherapy-Induced Nausea and Vomiting for Patients Receiving Multiday Cisplatin-Based Regimen: A Multicenter Trial.
Wei H, Sun Y, Xie L, Jia Y, He J, Deng X, Huang W, Hu Y, Zhu J. Wei H, et al. Among authors: zhu j. J Integr Complement Med. 2023 Aug;29(8):501-509. doi: 10.1089/jicm.2022.0672. Epub 2023 Mar 30. J Integr Complement Med. 2023. PMID: 36999940 Clinical Trial.
Incidence of chemotherapy-induced nausea and vomiting among cancer patients receiving moderately to highly emetogenic chemotherapy in cancer centers in Sichuan, China.
Sun Y, Zheng Y, Yang X, Xie K, Du C, He L, Gui Y, Fu J, Li C, Zhang H, Zhu L, Bie J, Sun Y, Fu Y, Zhou Y, Shou F, Wang Y, Zhu J. Sun Y, et al. Among authors: zhu j, zhu l. J Cancer Res Clin Oncol. 2021 Sep;147(9):2701-2708. doi: 10.1007/s00432-021-03554-1. Epub 2021 Feb 14. J Cancer Res Clin Oncol. 2021. PMID: 33586045
Stereotactic body radiotherapy to the primary lung lesion improves the survival of the selected patients with non-oligometastatic NSCLC harboring EGFR activating mutation with first-line EGFR-TKIs: a real-world study.
Wei H, Zhou X, Yang H, Gong Y, Wang J, Xu Y, Zhou L, Xue J, Zou B, Zhang Y, Zhu J, Peng F, Huang M, Lu Y, Liu Y. Wei H, et al. Among authors: zhu j. J Cancer Res Clin Oncol. 2022 Oct;148(10):2589-2598. doi: 10.1007/s00432-021-03831-z. Epub 2021 Oct 20. J Cancer Res Clin Oncol. 2022. PMID: 34669037
42,282 results
You have reached the last available page of results. Please see the User Guide for more information.